5DP6
Crystal Structure of EV71 3C Proteinase in complex with compound 7
5DP6 の概要
エントリーDOI | 10.2210/pdb5dp6/pdb |
関連するPDBエントリー | 5DP3 5DP4 5DP5 5DP7 5DP8 5DP9 5DPA |
分子名称 | 3C proteinase, ethyl (2Z,4S)-4-{[N-(3-cyclopropylpropanoyl)-L-phenylalanyl]amino}-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate (2 entities in total) |
機能のキーワード | hand, foot and mouth disease, 3c proteinase, peptidomimetics, drug design, rupintrivir, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
由来する生物種 | Enterovirus A71 |
細胞内の位置 | Host cytoplasm : A9XG43 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 86505.07 |
構造登録者 | |
主引用文献 | Wu, C.,Zhang, L.,Li, P.,Cai, Q.,Peng, X.,Yin, K.,Chen, X.,Ren, H.,Zhong, S.,Weng, Y.,Guan, Y.,Chen, S.,Wu, J.,Li, J.,Lin, T. Fragment-wise design of inhibitors to 3C proteinase from enterovirus 71 Biochim.Biophys.Acta, 1860:1299-1307, 2016 Cited by PubMed Abstract: Enterovirus 71 (EV71) is a causative agent of hand, foot and mouth disease (HFMD), which can spread its infection to central nervous and other systems with severe consequence. A key factor in the replication of EV71 is its 3C proteinase (3C(pro)), a significant drug target. Peptidomimetics were employed as inhibitors of this enzyme for developing antivirals. However, the peptide bonds in these peptidomimetics are a source of low bioavailability due to their susceptibility to protease digestion. To produce non-peptidomimetic inhibitors by replacing these peptide bonds, it would be important to gain better understanding on the contribution of each component to the interaction and potency. PubMed: 26987809DOI: 10.1016/j.bbagen.2016.03.017 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (3.01 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード